1. Hosomi S, Watabe T, Mori Y, Koyama Y, Adachi S, Hoshi N, Ohnishi M, Ogura H, Yoshioka Y, Hatazawa J, Yamashita T, Shimazu T. Inflammatory projections after focal brain injury trigger neuronal network disruption: An (18)F-DPA714 PET study in mice. Neuroimage Clin. 2018;20:946-954.
  2. Beshr R, Isohashi K, Watabe T, Naka S, Horitsugi G, Romanov V, Kato H, Miyatake SI, Shimosegawa E, Hatazawa J. Preliminary feasibility study on differential diagnosis between radiation-induced cerebral necrosis and recurrent brain tumor by means of [(18)F]fluoro-borono-phenylalanine PET/CT. Ann Nucl Med. 2018 Dec;32(10):702-708.
  3. Mori D, Miyagawa S, Yajima S, Saito S, Fukushima S, Ueno T, Toda K, Kawai K, Kurata H, Nishida H, Isohashi K, Hatazawa J, Sawa Y. Cell Spray Transplantation of Adipose-derived Mesenchymal Stem Cell Recovers Ischemic Cardiomyopathy in a Porcine Model. Transplantation. 2018 Dec;102(12):2012-2024.
  4. Kanai Y, Miyake Y, Shimosegawa E, Hatazawa J. Radiosynthesis of (11)C-phenytoin Using a DEGDEE Solvent for Clinical PET Studies. Asia Ocean J Nucl Med Biol. 2018 Spring;6(2):149-154.
  5. Aoe J, Watabe T, Shimosegawa E, Kato H, Kanai Y, Naka S, Matsunaga K, Isohashi K, Tatsumi M, Hatazawa J. Evaluation of the default-mode network by quantitative (15)O-PET: comparative study between cerebral blood flow and oxygen consumption. Ann Nucl Med. 2018 Aug;32(7):485-491.
  6. Miyajima N, Ito M, Rokugawa T, Iimori H, Momosaki S, Omachi S, Shimosegawa E, Hatazawa J, Abe K. Detection of neuroinflammation before selective neuronal loss appearance after mild focal ischemia using [(18)F]DPA-714 imaging. EJNMMI Res. 2018 Jun 8;8(1):43.
  7. Ikeda H, Hayashi Y, Takahashi N, Watabe T, Kanai Y, Shinohara A, Kato H, Watabe H, Shimosegawa E, Hatazawa J. Application of astatine-210: Evaluation of astatine distribution and effect of pre-injected iodide in whole body of normal rats. Appl Radiat Isot. 2018 Sep;139:251-255.
  8. Rokugawa T, Konishi H, Ito M, Iimori H, Nagai R, Shimosegawa E, Hatazawa J, Abe K. Evaluation of hepatic integrin αvβ3 expression in non-alcoholic steatohepatitis (NASH) model mouse by (18)F-FPP-RGD(2) PET. EJNMMI Res. 2018 May 31;8(1):40.
  9. Takano K, Kinoshita M, Arita H, Okita Y, Chiba Y, Kagawa N, Watanabe Y, Shimosegawa E, Hatazawa J, Hashimoto N, Fujimoto Y, Kishima H. Influence of region-of-interest designs on quantitative measurement of multimodal imaging of MR non-enhancing gliomas. Oncol Lett. 2018 May;15(5):7934-7940.
  10. Yajima S, Miyagawa S, Fukushima S, Sakai Y, Isohashi K, Watabe T, Ikeda H, Horitsugi G, Harada A, Sakaniwa R, Hatazawa J, Sawa Y. A prostacyclin agonist and an omental flap increased myocardial blood flow in a porcine chronic ischemia model. J Thorac Cardiovasc Surg. 2018 Jul;156(1):229-241.e14.
  11. Alobthani G, Romanov V, Isohashi K, Matsunaga K, Watabe T, Kato H, Tatsumi M, Shimosegawa E, Hatazawa J. Value of (18)F-FDG PET/CT in discrimination between indolent and aggressive non-Hodgkin's lymphoma: A study of 328 patients. Hell J Nucl Med. 2018 Jan-Apr;21(1):7-14.
  12. Matsuda H, Murata M, Mukai Y, Sako K, Ono H, Toyama H, Inui Y, Taki Y, Shimomura H, Nagayama H, Tateno A, Ono K, Murakami H, Kono A, Hirano S, Kuwabara S, Maikusa N, Ogawa M, Imabayashi E, Sato N, Takano H, Hatazawa J, Takahashi R. Japanese multicenter database of healthy controls for [(123)I]FP-CIT SPECT. Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1405-1416.
  13. Hatazawa J. (11)C-acetate PET/CT: a potential alternative of transcranial biopsy for grading cerebral gliomas. Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):1011.
  14. Kainuma S, Nakajima K, Miyagawa S, Fukushima S, Saito A, Harada A, Hirota M, Miyazaki Y, Sawabata N, Watabe T, Watabe H, Toda K, Hatazawa J, Okumura M, Sawa Y. Novel regenerative therapy combined with transphrenic peritoneoscopy-assisted omentopexy. Interact Cardiovasc Thorac Surg. 2018 Jun 1;26(6):993-1001.
  15. Hosono M, Ikebuchi H, Nakamura Y, Nakamura N, Yamada T, Yanagida S, Kitaoka A, Kojima K, Sugano H, Kinuya S, Inoue T, Hatazawa J. Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.). Ann Nucl Med. 2018 Apr;32(3):217-235.
  16. Morita T, Kurihara H, Hiroi K, Honda N, Igaki H, Hatazawa J, Arai Y, Itami J. Dynamic changes in (18)F-borono-L-phenylalanine uptake in unresectable, advanced, or recurrent squamous cell carcinoma of the head and neck and malignant melanoma during boron neutron capture therapy patient selection. Radiat Oncol. 2018 Jan 11;13(1):4.
  17. Kato H, Isohashi K, Shimosegawa E, Hatazawa J. Increase in extraction of I-123 iomazenil in patients with chronic cerebral ischemia. PLoS One. 2018 Jan 11;13(1):e0190720.
  18. Asai K, Nakamura H, Watabe T, Nishida T, Sakaguchi M, Hatazawa J, Yoshimine T, Kishima H. X-ray angiography perfusion imaging with an intra-arterial injection: comparative study with (15)O-gas/water positron emission tomography. J Neurointerv Surg. 2018 Aug;10(8):780-783.
  19. Kanoto M, Kirii K, Hiraka T, Toyoguchi Y, Sugai Y, Matsuda K, Sakurada K, Sonoda Y, Hatazawa J, Hosoya T. Correlation between hypoxic area in primary brain tumors and WHO grade: differentiation from malignancy using 18F-fluoromisonidazole positron emission tomography. Acta Radiol. 2018 Feb;59(2):229-235.
  20. Inubushi M, Tatsumi M, Yamamoto Y, Kato K, Tsujikawa T, Nishii R. European research trends in nuclear medicine. Ann Nucl Med. 2018 Nov;32(9):579-582. Ann Nucl Med. 2018 Nov;32(9):579-582.
  21. Sato TK, Asai M, Borschevsky A, Beerwerth R, Kaneya Y, Makii H, Mitsukai A, Nagame Y, Osa A, Toyoshima A, Tsukada K, Sakama M, Takeda S, Ooe K, Sato D, Shigekawa Y, Ichikawa S, Düllmann CE, Grund J, Renisch D, Kratz JV, Schädel M, Eliav E, Kaldor U, Fritzsche S, Stora T. First Ionization Potentials of Fm, Md, No, and Lr: Verification of Filling-Up of 5f Electrons and Confirmation of the Actinide Series. J Am Chem Soc. 2018 Oct;140(44):14609-14613.